21 October 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics investigates the use of Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection.
Unsatisfactory Helicobacter pylori eradication rates and therapy-associated side effects
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors